<code id='F7B64F6873'></code><style id='F7B64F6873'></style>
    • <acronym id='F7B64F6873'></acronym>
      <center id='F7B64F6873'><center id='F7B64F6873'><tfoot id='F7B64F6873'></tfoot></center><abbr id='F7B64F6873'><dir id='F7B64F6873'><tfoot id='F7B64F6873'></tfoot><noframes id='F7B64F6873'>

    • <optgroup id='F7B64F6873'><strike id='F7B64F6873'><sup id='F7B64F6873'></sup></strike><code id='F7B64F6873'></code></optgroup>
        1. <b id='F7B64F6873'><label id='F7B64F6873'><select id='F7B64F6873'><dt id='F7B64F6873'><span id='F7B64F6873'></span></dt></select></label></b><u id='F7B64F6873'></u>
          <i id='F7B64F6873'><strike id='F7B64F6873'><tt id='F7B64F6873'><pre id='F7B64F6873'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:27786
          Lee Klafczynski for STAT

          WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by.

          Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

          advertisement

          Politicians have been well aware of the problem for years. At the request of a large bipartisan group of lawmakers, a task force chaired by the Food and Drug Administration in 2019 reported on the root causes of drug shortages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          FDA's Woodcock to retire early next year
          FDA's Woodcock to retire early next year

          PrincipalDeputyFDACommissionerJanetWoodcockStefaniReynolds/TheNewYorkTimesviaAPWASHINGTON—PrincipalD

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Weight loss drug costs may need more research, senator suggests

          Sen.BillCassidy(R-La.)KevinDietsch/GettyImagesWASHINGTON—WithNovoNordisk’sWegovyandOzempichittingblo